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Vogt et al. demonstrate that, in mice, maternal high-fat feeding during lactation is sufficient to
program the offspring for impaired energy and glucose homeostasis throughout their lifetime.
They reveal that the resulting abnormal insulin signaling in the offspring interfereswith the formation
of hypothalamic neural circuits that contribute to metabolic status.In the first recorded case of diabetic preg-
nancy, almost 200 years ago, Bennewitz
from Munich, Germany described a
neonate as having ‘‘shoulders of such
width that he could not span their circum-
ference even with his fingers spread out’’
(Hadden and Hillebrand, 1989). The
concept of maternal or metabolic pro-
gramming provides one of many explana-
tions for this ongoing trend: women
with altered metabolic homeostasis (for
example, as a result of overnutrition)
during pregnancy are at increased risk to
deliver children that are more prone to
develop obesity, diabetes mellitus, or
cardiovascular diseases later in life (Sulli-
van and Grove, 2010). A study by Vogt
et al. (2014) now presents an analysis in
rodents on how the timing of maternal
high-fat diet (HFD) consumption impacts
development of neonatal neuronal cir-
cuitries that regulate feeding and glucose
homeostasis to impact the long-term
metabolic status of the offspring.
The incidence of obesity and T2DM
continues to rise, and the epidemic is
increasingly affecting people at younger
ages (Sabin and Shield, 2008). Although
numerous mechanisms have been pro-
posed to contribute to this metabolic
programming in the offspring, cross-
comparisons between studies appear
to be challenging given the high sensi-
tivity of both mother and offspring
during pregnancy/development to minor
changes in diet or environment. Thus,
the relative contribution of distinct hor-
mones during specific phases of develop-
ment in metabolic programming still
remains largely unknown. To shed new
light on these matters, Vogt et al. em-396 Cell 156, January 30, 2014 ª2014 Elsevieployed a thorough, well-controlled, and
physiological maternal high-fat feeding
paradigm in mice that clearly identifies
the early postnatal phase as themost sen-
sitive developmental period to maternal
HFD feeding (Vogt et al., 2014). Further-
more, the authors strategically investigate
possible underlying cellular andmolecular
mechanisms in the hypothalamus that are
responsible for the lifelong predisposition
for metabolic disorders and validate the
existence of yet another bogeyman to
blame for the never-ending rise of obesity
and T2DM—our own mothers.
The idea that maternal health, particu-
larly nutrition during pregnancy, affects
the propensity of the unborn child to
develop metabolic and cardiovascular
diseases has been postulated since the
early 20th century. Since then, the hypo-
thalamus has received extensive attention
as one of the main target sites of meta-
bolic programming because it is of central
importance for tight regulation of energy
and glucose homeostasis. The develop-
ment of hypothalamic neurocircuits can
be roughly divided into two major phases:
(1) cell number determination, including
neurogenesis and neuronal migration
and (2) neurocircuit formation, including
axon formation and synaptogenesis.
Though the sequence of events is thought
to be identical between rodents and hu-
mans, the relative timing is highly distinct
between species: unlike in humans,
wherein both phases of hypothalamic
neurocircuit development occur in utero,
in rodents, axon formation and synapto-
genesis occur during the first 3 weeks
after birth (Bouret et al., 2004a). Although
at first sight this discrepancy betweenr Inc.species seems like an obstacle, Vogt
et al. elegantly use these differences to
their advantage. By independently and
synergistically exposing female C57Bl/6
mice to HFD prior to birth and/or during
lactation, they could show that maternal
HFD feeding exclusively during lactation
exerts the strongest effects on the meta-
bolic phenotype in both male and female
offspring (Vogt et al., 2014). In contrast
to what has been suggested before
(Chen et al., 2009), established maternal
obesity and insulin resistance before
pregnancy accompanied by consistent
HFD feeding during gestation and lacta-
tion did not even closely resemble the
striking effects on body composition and
glucose homeostasis as the exclusive
exposure to malnutrition during the
early postnatal phase. Interestingly, the
offspring of mothers that consumed HFD
throughout, including the lactation phase,
were healthier than the offspring of
mothers who consumed HFD only during
the lactation phase. It is possible that
maternal HFD consumption in the prelac-
tation phase results in decreased insulin
sensitivity in the fetus, causing hypores-
ponsiveness to the detrimental effects of
the HFD consumed by the mother during
the lactation phase. In addition, maternal
obesity and insulin resistance prior to
gestation, with ‘‘healthy’’ food consump-
tion during lactation, partially protected
against the development of diet-induced
obesity during adulthood. The under-
lying molecular and cellular differences
responsible for this protection will require
further investigation.
So far, in this field of research, the focus
of attention has been on the role of the
adipocyte-derived hormone leptin during
neurocircuit development and thus pre-
disposition for metabolic disorders.
Different models of metabolic program-
ming lead to increased levels of leptin
during lactation in the offspring, which
has been shown to induce leptin resis-
tance early in life (Sun et al., 2012). Given
the well-described axonotrophic effect of
leptin on neurons of the arcuate nucleus
of the hypothalamus (ARH), particularly
during a critical time window in the post-
natal development (Bouret et al., 2004b),
it is conceivable that impaired axon for-
mation in response to neuronal leptin
resistance results in impaired energy and
glucose homeostasis. However, despite
the undisputable importance of balanced
leptin levels during development, other
factors are likely to contribute to the array
of metabolic insufficiencies of children
from obese, diabetic, or malnourished
mothers.
One of the most likely candidates to
mediate metabolic and cellular changes
in response to maternal health/feeding
behavior is the pancreatic hormone insu-
lin (Steculorum et al., 2013). Indeed,
human studies have shown that even
slightly elevated maternal glucose levels
during the last trimester of pregnancy
result in neonatal hyperinsulinemia and
increased birth weight, which has been
associated with elevated rates of meta-
bolic abnormalities throughout lifetime
(Group et al., 2008). However, the direct
cellular and molecular effects of hyperin-
sulinemia on the developing organism
are far from being understood. In line
with the results described in humans,
Vogt et al. demonstrate that maternalHFD feeding exclusively during lactation
(which corresponds to the third trimester
of pregnancy in humans with regards to
hypothalamic neurocircuit formation) is
sufficient to induce hyperinsulinemia in
the offspring by 3 weeks of age (Vogt
et al., 2014). Intriguingly, the authors
further dissect the specific consequences
of neuronal hyperinsulinemia in response
to maternal HFD feeding by specifically
abrogating insulin signaling from an
anorexigenic neuronal population, the
proopiomelanocortin (POMC) neurons
that reside in the ARH. POMC-specific
insulin receptor (IR) deletion in offspring
from postnatally HFD-fed mothers re-
stores POMC neuron fiber densities in a
hypothalamic target area that is impli-
cated in the regulation of the autonomic
nervous system and pancreatic para-
sympathetic innervation. Moreover, this
targeted deletion protects offspring
from glucose intolerance and restores
glucose-stimulated insulin secretion.
However, whether these findings are
causal and intimately linked with each
other or whether they reflect independent
secondary changes remains to be investi-
gated. Moreover, the question remains of
whether the observed effects of POMC IR
deficiency are highly specific or a general
phenomenon, for example, occurring
also in the POMC-opposing orexigenic
agouti-related peptide/neuropeptide Y-
coexpressing neurons. Nevertheless, the
current contribution by Vogt et al. strongly
adds to the understanding of the patho-
physiological effects of abnormal insulin
signaling in the hypothalamus during
development. It will also facilitate future
research on metabolic programming, asCell 156it justifies a primary focus onmanipulating
the early postnatal developmental period
in rodents to eventually understand
the obesity and T2DM epidemic from its
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